7th Dec 2007 18:26
GlaxoSmithKline PLC07 December 2007 Issued - Friday 7th December 2007 GLAXOSMITHKLINE PLC ANNOUNCES CHANGE TO BOARD COMMITTEE The Board has appointed Dr Stephanie Burns a member of the CorporateResponsibility Committee with immediate effect. A table showing the membership of the Board and its committees is attached. S M BicknellCompany Secretary7th December 2007 ________________________ BOARD AND COMMITTEE MEMBERSHIP WITH EFFECT FROM 7TH DECEMBER 2007* Sir Christopher Gent ChairmanSir Ian Prosser Senior Independent Non-Executive Director Dr J-P Garnier* Chief Executive OfficerMr Julian S Heslop Chief Financial OfficerDr Moncef Slaoui Executive Director, Chairman, Research & Development Professor Sir Roy Anderson Independent Non-Executive DirectorDr Stephanie Burns Independent Non-Executive DirectorMr H Lawrence Culp Independent Non-Executive DirectorSir Crispin Davis Independent Non-Executive DirectorSir Deryck Maughan Independent Non-Executive DirectorDr Dan Podolsky Independent Non-Executive DirectorDr Ronaldo Schmitz Independent Non-Executive DirectorMr Tom De Swaan Independent Non Executive DirectorSir Robert Wilson Independent Non-Executive Director Board Committee Committee Chairman Members Audit Mr Tom De Swaan Sir Deryck Maughan Dr Dan Podolsky Sir Ian Prosser Dr Ronaldo Schmitz Sir Robert Wilson Remuneration Sir Robert Wilson Mr H Lawrence Culp Sir Crispin Davis Sir Christopher Gent Dr Ronaldo Schmitz Nominations Sir Christopher Gent Sir Ian Prosser Dr Ronaldo Schmitz Corporate Responsibility Sir Christopher Gent Dr Stephanie Burns Sir Ian Prosser Dr Dan Podolsky Mr Tom de Swaan * Mr Andrew Witty, CEO Designate and Mr Chris Viehbacher, President, USPharmaceuticals will join the Board as Executive Directors on 31st January 2008 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline